Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA

S. Olofsson, O. Dahl, Mats Jerkeman, G. Cohn-Cedermark, O. Klepp, U. Stierner, M. Tornblom, R. Wahlqvist, Eva Cavallin-Ståhl

Research output: Contribution to journalPublished meeting abstractpeer-review

Original languageEnglish
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 2009
Event45th Annual Meeting of the American-Society-of-Clinical-Oncology - Orlando, FL
Duration: 2009 May 292009 Jun 2

Subject classification (UKÄ)

  • Cancer and Oncology

Cite this